Frequency- and Voltage-Dependent Depression of Maximum Upstroke Velocity of Action Potentials by Pirmenol in Guinea Pig Ventricular Muscles
Open Access
- 1 January 1988
- journal article
- research article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 48 (4) , 423-434
- https://doi.org/10.1254/jjp.48.423
Abstract
The frequency-dependency and voltage-dependency of the suppressing effect of pirmenol, a novel antiarrhythmic agent, on the maximum upstroke velocity (.ovrhdot.Vmax) of action potentials were examined and compared with those of disopyramide in guinea pig papillary muscles. Pirmenol in concentrations higher than 3 .mu.M decreased .ovrhdot.Vmax with a slight increase in action potential duration. The reduction of .ovrhdot.Vmax by pirmenol was enhanced in a frequency-dependent manner over the range of 0.1-2.0 Hz. Pirmenol (30 .mu.M) produced a small resting block (5.5%), whereas disopyramide (100 .mu.M) produced a greater one (25.8%). The onset of frequency-dependent .ovrhdot.Vmax reduction at 2.0 Hz followed a monoexponential function with a slow rate constant (0.308 .+-. 0.055 AP-1). The time constant for the recovery from the frequency-dependent block by pirmenol was also slow (33.5 .+-. 5.4 sec), but faster than that of disopyramide (82.5 .+-. 12.3 sec). At 1.0 Hz, pirmenol caused a shift (9.5 mV) of the curve relating the resting membrane potential and .ovrhdot.Vmax along the voltage axis in the hyperpolarizing direction. Thus, pirmenol is a Class Ia drug that has frequency- and voltage-dependent inhibitory actions on .ovrhdot.Vmax, and its onset and offset kinetics are relatively slow.This publication has 27 references indexed in Scilit:
- Preclinical pharmacology of pirmenolThe American Journal of Cardiology, 1987
- Block of activated and inactivated sodium channels by class-I antiarrhythmic drugs studied by using the maximum upstroke velocity (V̇max) of action potential in guinea-pig cardiac musclesJournal of Molecular and Cellular Cardiology, 1987
- Antiarrhythmic Agents: The Modulated Receptor Mechanism of Action of Sodium and Calcium Channel-Blocking DrugsAnnual Review of Pharmacology and Toxicology, 1984
- A Classification of Antiarrhythmic Actions Reassessed After a Decade of New DrugsThe Journal of Clinical Pharmacology, 1984
- Antiarrhythmic treatment: An overviewThe American Journal of Cardiology, 1984
- Pharmacokinetics and Efficacy of Pirmenol Hydrochloride in the Treatment of Ventricular DysrhythmiaJournal of Cardiovascular Pharmacology, 1983
- Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassificationCardiovascular Research, 1983
- Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics.Circulation, 1982
- Encainide: A new and potent antiarrhythmic agentAmerican Heart Journal, 1980
- Interval-dependent effects of small antiarrhythmic drugs on excitability of guinea-pig myocardiumJournal of Molecular and Cellular Cardiology, 1980